Chiropractors in Kings Park, NY Accepting Medicare

5 Chiropractors found. Showing 1 - 5

Northside Chiropractic Center Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 185 Main St, Kings Park, NY 11754 Phone: 631-544-0770

Dr. Michael Joseph Sredniawski, DC Chiropractor Medicare: May Accept Medicare Assignments Practice Location: 12 Renwick Ave, Kings Park, NY 11754 Phone: 631-663-5555

Michael J Sredniawski, Dc, Pc Chiropractor Medicare: Medicare Enrolled Practice Location: 12 Renwick Ave, Kings Park, NY 11754 Phone: 631-663-5555

Prevent-a-stress Chiropractic, Pc Chiropractor Medicare: Not Enrolled in Medicare Practice Location: 102 Main St, Kings Park, NY 11754 Phone: 631-764-8000

Alan R Friedman Chiropractor Medicare: Accepting Medicare Assignments Practice Location: 185 Main Street, Kings Park, NY 11754 Phone: 631-544-0770    Fax: 631-544-4157

News Archive

Valeant enters into definitive agreement to acquire Sprout Pharmaceuticals

Valeant Pharmaceuticals International, Inc. and Sprout Pharmaceuticals, Inc. today announced that they have entered into a definitive agreement under which a wholly-owned subsidiary of Valeant will acquire Sprout, on a debt-free basis, for approximately $1 billion in cash, plus a share of future profits based upon the achievement of certain milestones.

Release of blood stem cells from bone marrow is regulated by brain through human biological clock

These new findings, published online on the website of the journal Nature, point out that the harvest of stem cells for transplantation may be improved by timing it at the peak of their release.

Spending $5 billion a year on tobacco cessation for 25 years would profoundly improve the health of Americans

An article published in the Sept. 8, 2005 New England Journal of Medicine sheds new light on the $130 billion smoking cessation plan proposed in the Department of Justice suit against the tobacco companies.

Curemark receives FDA clearance for enrollment of children aged 9-12 in CM-AT study for autism

Dr. Joan Fallon, founder and CEO of Curemark, a Rye, New York-based drug research and development company focused on the treatment of Autism and neurological diseases, today announced that the company has received clearance from the Food and Drug Administration (FDA) to commence direct enrollment of children 9-12 years of age into its open-label extension study of CM-AT for children with Autism.

Researchers pave way for development of new generation of chemotherapy drugs

A new mechanism to inhibit proteasomes, protein complexes that are a target for cancer therapy, is the topic of an article published in the journal Chemistry & Biology.

Read more Medical News

› Verified 7 days ago